BRIGHT MINDS BIOSCIENCES INC (DRUG:NASDAQ)
$51.3 -2.91 (-5.368%)
Analysed BRIGHT MINDS BIOSCIENCES INC (DRUG:NASDAQ) News Sources
Bright Minds Biosciences to Present at Upcoming Conferences
04-09-2026
yahoo.com
3 Small Cap Stocks With Strong Revenue Growth And Low Debt
16-09-2026
yahoo.com
Auxly Cannabis Group And 2 Other Canadian Biotech Stocks To Watch
30-09-2026
yahoo.com
3 Canadian Biotech Stocks Trading Up To 93% Below Fair Value
15-10-2026
yahoo.com
All You Need to Know About Bright Minds Biosciences Inc. (DRUG) Rating Upgrade to Strong Buy
22-07-2026
yahoo.com
Wall Street Analysts See a 107.53% Upside in Bright Minds Biosciences Inc. (DRUG): Can the Stock Really Move This High?
23-07-2026
yahoo.com
Wall Street Analysts See a 97.01% Upside in Bright Minds Biosciences Inc. (DRUG): Can the Stock Really Move This High?
26-08-2026
yahoo.com
What Makes Bright Minds Biosciences Inc. (DRUG) a Strong Momentum Stock: Buy Now?
27-08-2026
yahoo.com
Bright Minds Biosciences to Participate in the 2026 FPWR Research Symposium and PWS Family Conference
30-09-2026
yahoo.com
Bright Minds Biosciences And 2 More Canadian Biotech Stocks
08-10-2026
yahoo.com
What is the current price of BRIGHT MINDS BIOSCIENCES INC (DRUG:NASDAQ)?
The current price of BRIGHT MINDS BIOSCIENCES INC (DRUG:NASDAQ) is $51.3.
BRIGHT MINDS BIOSCIENCES INC (DRUG:NASDAQ) absolute price change since previous trading day?
The absolute price change of BRIGHT MINDS BIOSCIENCES INC (DRUG:NASDAQ) since the previous trading day is $-2.91.
BRIGHT MINDS BIOSCIENCES INC (DRUG:NASDAQ) percentage price change since previous trading day?
The percentage price change of BRIGHT MINDS BIOSCIENCES INC (DRUG:NASDAQ) since the previous trading day is -5.368%.
What is the most recent average sentiment score for BRIGHT MINDS BIOSCIENCES INC (DRUG:NASDAQ)?
The most recent average sentiment score for BRIGHT MINDS BIOSCIENCES INC (DRUG:NASDAQ) is 73 out of 100.
What is the most recent average sentiment for BRIGHT MINDS BIOSCIENCES INC (DRUG:NASDAQ)?
The most recent sentiment for BRIGHT MINDS BIOSCIENCES INC (DRUG:NASDAQ) is .
SEC-8K** Filing Available For BRIGHT MINDS BIOSCIENCES INC (DRUG:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.